PAG
REGN icon

Private Advisor Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Private Advisor Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6M Buy
18,557
+1,242
+7% +$845K 0.05% 352
2026
Q1 		$13.4M Sell
17,315
-453
-3% -$347K 0.06% 323
2025
Q4 		$13.7M Sell
17,768
-4,054
-19% -$2.75M 0.06% 308
2025
Q3 		$12.3M Buy
21,822
+2,631
+14% +$1.49M 0.06% 323
2025
Q2 		$10.1M Buy
19,191
+4,915
+34% +$2.74M 0.05% 363
2025
Q1 		$9.05M Buy
14,276
+1,957
+16% +$1.35M 0.05% 360
2024
Q4 		$8.77M Buy
12,319
+6,958
+130% +$5.84M 0.05% 358
2024
Q3 		$5.64M Buy
5,361
+303
+6% +$337K 0.04% 478
2024
Q2 		$5.32M Buy
5,058
+354
+8% +$343K 0.04% 461
2024
Q1 		$4.53M Sell
4,704
-180
-4% -$171K 0.03% 486
2023
Q4 		$4.29M Sell
4,884
-58
-1% -$47.8K 0.03% 489
2023
Q3 		$4.06M Buy
4,942
+714
+17% +$561K 0.04% 465
2023
Q2 		$3.05M Buy
4,228
+399
+10% +$308K 0.03% 559
2023
Q1 		$3.15M Buy
3,829
+212
+6% +$160K 0.03% 526
2022
Q4 		$359K Sell
3,617
-93
-3% -$68.6K 0.02% 687
2022
Q3 		$2.56M Sell
3,710
-3,145
-46% -$1.98M 0.03% 541
2022
Q2 		$4.05M Sell
6,855
-1,573
-19% -$1.02M 0.04% 471
2022
Q1 		$5.89M Sell
8,428
-3,447
-29% -$2.18M 0.05% 389
2021
Q4 		$7.5M Sell
11,875
-8,471
-42% -$5.21M 0.06% 332
2021
Q3 		$12.3M Buy
20,346
+2,948
+17% +$1.83M 0.08% 250
2021
Q2 		$9.72M Buy
17,398
+1,695
+11% +$859K 0.08% 238
2021
Q1 		$7.43M Buy
15,703
+5,246
+50% +$2.55M 0.07% 276
2020
Q4 		$5.05M Buy
10,457
+1,239
+13% +$669K 0.05% 332
2020
Q3 		$5.34M Buy
9,218
+2,167
+31% +$1.31M 0.07% 266
2020
Q2 		$4.4M Buy
7,051
+1,260
+22% +$715K 0.06% 299
2020
Q1 		$2.83M Buy
5,791
+158
+3% +$65.2K 0.05% 338
2019
Q4 		$2.12M Buy
5,633
+220
+4% +$74K 0.03% 515
2019
Q3 		$1.5M Buy
5,413
+2,276
+73% +$674K 0.02% 629
2019
Q2 		$982K Sell
3,137
-204
-6% -$67.9K 0.02% 751
2019
Q1 		$1.37M Sell
3,341
-359
-10% -$148K 0.03% 552
2018
Q4 		$1.38M Buy
3,700
+17
+0.5% +$6.22K 0.03% 484
2018
Q3 		$1.49M Sell
3,683
-84
-2% -$32K 0.03% 515
2018
Q2 		$1.32M Buy
3,767
+786
+26% +$246K 0.02% 396
2018
Q1 		$1.03M Sell
2,981
-496
-14% -$173K 0.04% 406
2017
Q4 		$1.3M Sell
3,477
-916
-21% -$371K 0.05% 351
2017
Q3 		$2.06M Buy
4,393
+159
+4% +$75.7K 0.05% 355
2017
Q2 		$2.12M Buy
4,234
+124
+3% +$54.3K 0.06% 323
2017
Q1 		$1.55M Sell
4,110
-86
-2% -$31.9K 0.04% 413
2016
Q4 		$1.53M Buy
4,196
+490
+13% +$186K 0.05% 370
2016
Q3 		$1.47M Sell
3,706
-87
-2% -$34.9K 0.06% 319
2016
Q2 		$1.41M Sell
3,793
-193
-5% -$74.3K 0.06% 318
2016
Q1 		$1.18M Buy
3,986
+1,480
+59% +$610K 0.06% 331
2015
Q4 		$1.36M Buy
2,506
+371
+17% +$201K 0.07% 313
2015
Q3 		$993K Sell
2,135
-1,769
-45% -$950K 0.05% 363
2015
Q2 		$1.99M Buy
+3,904
New +$1.91M 0.09% 217

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Private Advisor Group's REGN Position: Q2 2026 in Review

Private Advisor Group increased its Regeneron Pharmaceuticals (REGN) stake by 7.2% in Q2 2026, buying an estimated $845K and bringing the position to 18,557 shares worth $11.6M. The position accounts for 0.05% of the portfolio, ranked #352.

Private Advisor Group first reported a position in REGN in Q2 2015 and has held it in 45 quarters since. The position peaked at $13.7M in Q4 2025. 454 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Private Advisor Group held 18,557 shares of Regeneron Pharmaceuticals worth $11.6M as of Q2 2026.
  • Private Advisor Group bought 1,242 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $845K.
  • Regeneron Pharmaceuticals made up 0.05% of Private Advisor Group's portfolio in Q2 2026, its #352 holding.
  • Private Advisor Group first reported a position in Regeneron Pharmaceuticals in Q2 2015 and has held it in 45 quarters since.
  • Private Advisor Group's Regeneron Pharmaceuticals position peaked at $13.7M in Q4 2025.
  • 454 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.